Biotech companies continue to make profits at the expense of - TopicsExpress



          

Biotech companies continue to make profits at the expense of health by using genetic engineering to alter the breeding objectives in several countries. In 2009, China approved its first strain of genetically modified rice for commercial production. Tufts University researchers in Boston swapped the term "genetically modified" (GM) for "nutritionally enhanced" so they could proceed with a study testing GM rice on six to eight-year olds.
Posted on: Fri, 26 Jul 2013 23:11:51 +0000

Trending Topics



Recently Viewed Topics




© 2015